Magnesium for Headaches and Migraines: The Clinical Evidence

The case for using magnesium for headaches and migraines is one of the better-supported applications of any mineral in preventive medicine. Unlike many supplement categories where the evidence is extrapolated from cellular studies, magnesium's role in migraine pathophysiology is understood at a mechanistic level, backed by IV administration studies in emergency settings and confirmed by multiple oral supplementation RCTs.

The Evidence Base: RCTs, Guidelines, and Real-World Data

The American Migraine Foundation and American Academy of Neurology both recognize magnesium supplementation as a preventive migraine therapy — a distinction very few supplements achieve. The evidence includes:

A 1996 RCT by Peikert et al. in Cephalalgia found 600 mg/day of trimagnesium dicitrate reduced migraine attack frequency by 41.6% versus 15.8% in placebo over 12 weeks. Schwalfenberg and Genuis (2017) in Scientifica reviewed magnesium's clinical relevance across multiple conditions and confirmed migraine as one of the strongest indications. A 2016 meta-analysis by Zhang et al. in Hypertension documented consistent blood pressure effects, and the same vascular mechanisms are relevant to migraine pathophysiology.

In acute settings, IV magnesium sulfate (1–2 g) is used in emergency departments for status migrainosus — treatment-refractory migraines. This provides strong proof-of-concept for the mechanism; oral supplementation works via the same pathways but more slowly and at lower serum concentrations.

Importantly, Veronese et al. (2021) in Eur J Nutr found oral magnesium supplementation significantly reduced oxidative stress markers — relevant because oxidative stress is increasingly recognized as a contributing factor in chronic migraine.

The Mechanism: Why Magnesium Matters for Migraine

Magnesium acts on multiple nodes in migraine physiology:

The form of magnesium matters significantly for headache and migraine prevention:

Magnesium Form	Bioavailability	Headache / Migraine Evidence	Typical Dose
Magnesium Citrate	Moderate-High	High — most studied for migraine prophylaxis (Peikert et al. 1996)	400–600 mg/day
Magnesium Glycinate	High	Moderate-High — well absorbed; good tolerability for daily use	300–400 mg/day
Magnesium L-Threonate	High (CNS-targeted)	Moderate — crosses blood-brain barrier; supports neurological function	1,500–2,000 mg/day (delivers ~140 mg elemental Mg)
Magnesium Taurate	High	Moderate — taurine component supports neuronal stability	200–400 mg/day elemental Mg
Magnesium Oxide	Low (~4%)	Low — poor absorption limits clinical utility despite low cost	Not recommended for migraine
IV Magnesium Sulfate	100% (IV)	High — used acutely in clinical settings for severe migraine attacks	1–2 g IV (clinical use only)

NMDA receptor modulation: Magnesium blocks NMDA glutamate receptors at rest. When magnesium is deficient, these receptors become hyperexcitable, lowering the threshold for cortical spreading depression (CSD) — the neurological event underlying migraine aura and triggering trigeminal pain pathways.

Serotonin receptor regulation: Low magnesium impairs serotonin (5-HT) receptor function and reduces serotonin synthesis. Serotonin dysregulation is a central feature of migraine neurobiology — it's why triptans (5-HT1B/1D agonists) are first-line acute treatments.

Platelet aggregation and vascular tone: Magnesium modulates calcium-mediated vasoconstriction. Deficiency increases platelet aggregation and promotes arterial vasospasm, contributing to the vascular component of migraine attacks.

Neuromuscular excitability: Magnesium stabilizes nerve cell membranes generally. Low levels increase excitability across pain-processing neurons, amplifying nociceptive signaling.

The net effect of magnesium deficiency is a nervous system that is essentially primed for migraine. Studies consistently find that serum and ionized magnesium levels are lower in migraine patients compared to controls — and lowest during active attacks.

Form Matters: Which Magnesium Works Best for Headaches?

Not all magnesium forms are equivalent in bioavailability or tolerability:

Magnesium glycinate is among the best-absorbed oral forms, with high elemental magnesium content and excellent GI tolerability. It's the form least likely to cause the laxative effect that limits dosing with magnesium oxide. For preventive migraine use requiring sustained higher doses (300–600 mg elemental), glycinate is the practical choice for most people.

Magnesium oxide has poor bioavailability (<4% absorbed) despite appearing in many studies at 400–500 mg doses. Some positive migraine RCTs used oxide, which suggests the absolute absorbed amount may still be sufficient — but you'll need higher doses and should expect more GI side effects.

Magnesium citrate is well-absorbed and widely available, with slightly more laxative effect than glycinate at equivalent doses. A reasonable middle-ground option.

Magnesium taurate may have specific advantages for cardiovascular applications given taurine's cardiovascular effects, but isn't specifically better-studied for migraine than glycinate.

For a detailed comparison of forms, see our Magnesium Forms Comparison article. For the case against magnesium oxide specifically, see our Magnesium Glycinate Guide.

Dosing Protocol for Migraine Prevention

The clinical evidence cluster around 400–600 mg elemental magnesium daily for migraine prevention. Key practical points:

Response time is 8–12 weeks minimum. Magnesium supplementation works by gradually repleting tissue stores — which can take months to fully restore if significantly depleted. Studies that found no effect at 4 weeks were likely assessing too early.

Tolerance development is not an issue — magnesium is not pharmacologically active in the way drugs are. Continued supplementation maintains tissue levels and continued migraine-preventive effect.

Splitting the dose (e.g., 200 mg morning, 200 mg evening) improves absorption and reduces GI side effects at higher doses.

Gröber et al. (2015) in Nutrients noted that magnesium requirements are significantly higher in people with chronic stress, poor dietary quality, or high physical activity — all common migraine risk factors. This population is particularly likely to be deficient and to benefit from supplementation. Their comprehensive review also confirmed the importance of long-term magnesium sufficiency for both prevention and general neurological health.

Who Benefits Most

The evidence is strongest for:

• People with frequent migraines (≥4/month): This is the population used in most prevention RCTs. Occasional tension headache sufferers have less evidence for magnesium specifically, though GI tolerance and low risk make a trial reasonable.
• Menstrual migraine sufferers: Magnesium levels fluctuate with the hormonal cycle, and several studies specifically show benefit for perimenstrual migraines. Supplementing in the two weeks before menstruation is a studied approach.
• People with migraine aura: Cortical spreading depression — the mechanism underlying aura — is particularly linked to NMDA hyperexcitability and therefore to magnesium's mechanism of action.
• Those with poor dietary intake: Western diets average only 60–70% of the recommended daily magnesium intake. Subclinical deficiency is common, and supplementation is effectively correcting a deficit rather than pharmacologically treating a normal state.

For additional context on magnesium's broader role, see our article on Magnesium and Migraines.

Practical Takeaways

• 300–400 mg elemental magnesium glycinate daily is a well-tolerated preventive protocol. Work up from 150 mg/day to assess GI tolerance before increasing dose.
• Give it at least 10–12 weeks before evaluating response. Migraine frequency is your primary metric, not how you feel day-to-day.
• Take with food to minimize GI effects. Evening dosing may also support sleep quality (an important migraine trigger).
• Avoid magnesium oxide if you can — poor bioavailability means you need much higher doses for the same effect, increasing GI side effects.
• Bio:sudo Magnesium Glycinate provides 300 mg elemental magnesium per serving in glycinate chelate form — the most practical choice for sustained preventive dosing.
• Magnesium doesn't replace acute migraine medication. It's preventive — think of it as lowering your baseline excitability, not aborting attacks.

Bottom Line

Magnesium has one of the strongest evidence bases of any supplement for migraine prevention, supported by RCTs, mechanistic clarity, and recognition in clinical guidelines. The evidence is not perfect — most trials are small, and response rates are not 100% — but compared to the risk and cost profile, oral magnesium glycinate at 300–600 mg elemental daily is a very reasonable first-line preventive strategy for migraine sufferers, especially those with menstrual migraines or aura. Results take time to manifest; patience and consistent supplementation over 3 months gives you a fair assessment window.

References

1. Schwalfenberg GK, Genuis SJ. "The importance of magnesium in clinical healthcare." Scientifica. 2017;2017:4179326. [Source]
2. Abbasi B, et al. "The effect of magnesium supplementation on primary insomnia in elderly." J Res Med Sci. 2012;17(12):1161–1169. [Source]
3. Gröber U, et al. "Magnesium in prevention and therapy." Nutrients. 2015;7(9):8199–8226. [Source]
4. Zhang X, et al. "Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials." Hypertension. 2016;68(2):324–333. [Source]
5. Veronese N, et al. "Effect of magnesium supplementation on oxidative stress in humans: a systematic review." Eur J Nutr. 2021;60(4):2049–2063. [Source]

---

---